Skip to main content
Clinical Trials/NCT04444661
NCT04444661
Completed
Not Applicable

Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise in Older Men With Osteosarcopenia A Randomized Controlled Trial

University of Erlangen-Nürnberg Medical School1 site in 1 country21 target enrollmentJune 10, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoporosis
Sponsor
University of Erlangen-Nürnberg Medical School
Enrollment
21
Locations
1
Primary Endpoint
SMI
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Osteosarcopenia designates the simultaneous presence of sarcopenia and osteopenia; both chronic conditions of advanced age. Dynamic-resistance exercise (DRT) might be the most powerful agent to fight osteosarcopenia. Indeed, in the present FrOST study, we clearly determine the positive effect of slightly adapted 18 month high-intensity (HIT)-DRT on bone mineral density (BMD), sarcopenia and other health related parameters in osteosarcopenic men. However, after a short training break, COVID-19 induced lock down prevented a re-start of the HIT resistance exercise training in the FrOST cohort.

The aim of the present observational study is thus to determine the effects of 6 months of deconditioning on health related parameters under special regard of osteosarcopenia in this cohort of older men with osteosarcopenia.

Registry
clinicaltrials.gov
Start Date
June 10, 2020
End Date
December 31, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
University of Erlangen-Nürnberg Medical School
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • participants of the FrOST study (NCT03453463)

Exclusion Criteria

  • medication and diseases with potential impact on study outcomes during the last 26 weeks.

Outcomes

Primary Outcomes

SMI

Time Frame: Change from Baseline to 26 weeks

Skeletal muscle mass index (appendicular skeletal muscle mass / body height; kg/m2) as determined by Dual Energy x-Ray Absorptiometry

Secondary Outcomes

  • Maximum hip-/leg extensor strength(Change from Baseline to 26 weeks)
  • BMD-hip(Change from Baseline to 26 weeks)
  • Metabolic Syndrome Z-Score(Change from Baseline to 26 weeks)
  • BMD-LS(Change from Baseline to 26 weeks)
  • Fat infiltration thigh muscles(Change from Baseline to 26 weeks)
  • Fat infiltration para-vertebral muscles(Change from Baseline to 26 weeks)
  • Self rated physical performance(Change from Baseline to 26 weeks)
  • Sarcopenia-Z-Score(Change from Baseline to 26 weeks)

Study Sites (1)

Loading locations...

Similar Trials